Clinical trial for secondary ER-positive, HER2-negative breast cancer
Take part in a clinical trial exploring whether adding a drug called ipatasertib to standard treatment can improve people’s response to brea...
article
Personal diagnosis
schedule
Ongoing
calendar_today
Closing date: 03 Jul 2030